Thomas Efferth

Thomas Efferth is Full Professor and Director of the Institute of Pharmaceutical and Biomedical Sciences at Johannes Gutenberg University Mainz, Germany. He leads the Department of Pharmaceutical Biology, specializing in molecular pharmacology and drug discovery. His research spans cancer therapeutics, infectious diseases, and traditional Chinese medicine, with a strong focus on artemisinin and natural products.

Education includes a PhD from the German Cancer Research Center (1990) and habilitation from RWTH Aachen University (1997). Professional positions include research leadership at the German Cancer Research Center (2005), associate professorship at Heidelberg University (2007), and his current role since 2009.

Research interests integrate systems biology approaches with:

• Molecular mechanisms of anticancer drugs
• Bioinformatic pharmacology for personalized medicine
• Artemisinin repurposing for cancer/viral infections
• Toxicological profiling of natural products

Publications demonstrate strong focus on phytomedicine, antiviral therapies, and cancer drug resistance.

Awards and honors include:

• Qihuang International Award (2017)
• World Academy of Sciences membership (2018)
• Stanford Top 2% Scientist citation ranking (2020)
• Dr. Wilmar Schwabe Award (2006)
• Multiple honorary professorships in China/Hong Kong

Editorial leadership includes Editor-in-Chief roles for Phytomedicine and board memberships in 20+ journals. Society roles feature vice-presidency of the Specialty Committee on Immunology of TCM and executive positions in IUPHAR and DPhG.